Iida-Miwa, Yuko
Muraoka, Yuki
Iida, Yuto http://orcid.org/0000-0002-7472-6002
Ooto, Sotaro
Murakami, Tomoaki
Suzuma, Kiyoshi
Tsujikawa, Akitaka
Funding for this research was provided by:
the Japan Society for the Promotion of Science (JSPS), Tokyo, Japan
Article History
Received: 20 August 2018
Accepted: 8 April 2019
First Online: 25 April 2019
Competing Interests
: None of the authors has a proprietary interest in any product described in the article. Yuki Muraoka received grant support from Bayer, Novartis Pharma K.K., Senju and Nidek. Sotaro Ooto received grant support from Alcon Pharma, Bayer, Santen, Senju, Japan Focus, Nidek, and Pfizer. Kiyoshi Suzuma received grant support from Novartis Pharma K.K., Bayer, Nihon Alcon, Santen, Senju, HOYA, Topcon, Nidek, SANWA KAGAKU, SANOFI, Kowa-Pharmaceutical, Bausch & Lomb, Otsuka Pharmaceutical, Pfizer, and WAKAMOTO. Tomoaki Murakami received grant support from Bayer, Novartis Pharma K.K., Santen, Senju, Kowa-Pharmaceutical, and SANWA KAGAKU, as well as financial support from Novartis Pharma K.K. Akitaka Tsujikawa received grant support from Pfizer, Novartis Pharma K.K., Bayer, Alcon, Santen, Senju, Nidek, AMO Japan, Kowa-Pharmaceutical, Chugai Pharmaceutical, SANWA KAGAKU, Kyoto Drug Discovery & Development, HOYA, Otsuka Pharmaceutical, Daiichi-Sankyo Company, WAKAMOTO, Johnson and Johnson, and Janssen Pharmaceutical K.K., as well as financial support from Novartis Pharma K.K., Bayer, Santen, Canon, Alcon, Alcon Pharma, HOYA, Kowa-Pharmaceutical, Pfizer, AMO Japan, Senju, WAKAMOTO, JMIA, Tomey Corporation, JFC Sales Plan, and Atsuzawa Prosthese Osaka. The following authors have no conflicts of interest to declare: Yuko Iida-Miwa, Yuto Iida.